A cancer precision medicine platform for multiple simultaneous genomic assays from metastatic biopsies (bx) in ER plus metastatic breast cancer.

被引：0
|
作者：
Wagle, Nikhil
Helvie, Karla
Lloyd, Maxwell R.
Marini, Lori
Waks, Adrienne Gropper
Cohen, Ofir
Oh, Coyin
Sougnez, Carrie
Oliver, Nelly
Quartey, Qaren
Rotem, Asaf
Shah, Parin
Lindeman, Neal Ian
Krop, Ian E.
Garraway, Levi A.
Winer, Eric P.
Lin, Nancy U.
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Broad Inst, Cambridge, MA USA
[3] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.11513
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11513
引用
收藏
页数：2
相关论文
共 50 条
  • [31] ConvertHER: Evolution of genomic alterations from primary to metastatic breast cancer
    Gonzalez-Angulo, Ana Maria
    Lluch, Ana
    Eterovic, Agda K.
    Guerrero, Angel
    Zheng, Xiaofeng
    Perez, Ramon
    Liu, Shuying
    Chacon, Jose I.
    Chen, Ken
    Antolin, Silvia
    Mills, Gordon B.
    Ferrer, Jaime
    Burgues, Octavio
    Bermejo, Begona
    Munoz, Elia
    Caballero, Rosalia
    Carrasco, Eva
    Martinez, Eduardo
    Meric-Bernstam, Funda
    CANCER RESEARCH, 2015, 75
  • [32] Moving toward precision medicine to predict drug sensitivity in patients with metastatic breast cancer
    Bottosso, M.
    Mosele, F.
    Michiels, S.
    Cournede, P. -H.
    Dogan, S.
    Labaki, C.
    Andre, F.
    ESMO OPEN, 2024, 9 (03)
  • [33] Evolutionary analysis of 462 serial metastatic biopsies from 208 patients with estrogen receptor-positive (ER plus ) metastatic breast cancer (MBC) using whole exome sequencing (WES)
    Cohen, O.
    Buendia-Buendia, J.
    Wander, S.
    Nayar, U.
    Mao, P.
    Waks, A.
    Kim, D.
    Freeman, S.
    Adalsteinsson, V.
    Helvie, K.
    Livitz, D.
    Rosebrock, D.
    Leshchiner, I.
    Dellostritto, L.
    Garrido-Castro, A.
    Jain, E.
    Periyasamy, S.
    Mackichan, C.
    Lloyd, M.
    Marini, L.
    Krop, I.
    Garraway, L.
    Getz, G.
    Winer, E.
    Lin, N.
    Wagle, N.
    CANCER RESEARCH, 2019, 79 (04)
  • [34] Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial
    Yi-Zhou Jiang
    Yin Liu
    Yi Xiao
    Xin Hu
    Lin Jiang
    Wen-Jia Zuo
    Ding Ma
    Jiahan Ding
    Xiaoyu Zhu
    Jianjun Zou
    Claire Verschraegen
    Daniel G. Stover
    Virginia Kaklamani
    Zhong-Hua Wang
    Zhi-Ming Shao
    Cell Research, 2021, 31 : 178 - 186
  • [35] Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial
    Jiang, Yi-Zhou
    Liu, Yin
    Xiao, Yi
    Hu, Xin
    Jiang, Lin
    Zuo, Wen-Jia
    Ma, Ding
    Ding, Jiahan
    Zhu, Xiaoyu
    Zou, Jianjun
    Verschraegen, Claire
    Stover, Daniel G.
    Kaklamani, Virginia
    Wang, Zhong-Hua
    Shao, Zhi-Ming
    CELL RESEARCH, 2021, 31 (02) : 178 - 186
  • [36] The mutational profile of ER-, PR+, HER2-metastatic breast cancer.
    Fischbach, Neal A.
    Huang, Richard S. P.
    Lustberg, Maryam B.
    Pelletier, Maureen
    Pusztai, Lajos
    Sivakumar, Smruthy
    Sokol, Ethan
    Ross, Jeffrey S.
    Levy, Mia Alyce
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [37] Hybrid capture-based genomic profiling of circulating tumor DNA from patients with metastatic breast cancer.
    Guan, Xiaoxiang
    Zhu, Hong
    Xie, Wenzhuan
    Zhao, Jing
    Wang, Guoqiang
    Zhang, Yuzi
    Zhao, Zhengyi
    Cai, Shangli
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [38] A role for fulvestrant monotherapy in the first-line treatment of ER plus metastatic breast cancer?
    Mahtani, Reshma L.
    BREAST JOURNAL, 2020, 26 (02): : 109 - 111
  • [39] ER plus metastatic breast cancer: past, present, and a prescription for an apoptosis-targeted future
    Rozeboom, Brett
    Dey, Nandini
    De, Pradip
    AMERICAN JOURNAL OF CANCER RESEARCH, 2019, 9 (12): : 2821 - 2831
  • [40] CDK 4/6 Inhibitors: Evolution and Revolution in the Management of ER plus Metastatic Breast Cancer
    Reddy, Priyanka M.
    Martin, James M.
    Montero, Alberto J.
    JCO ONCOLOGY PRACTICE, 2022, 18 (05) : 329 - +
12345